Withdrawn Post Marketing

December 01, 2022

US FDA approval tracker: November 2022

November 22, 2022

GSK’s “crown jewels” already look tarnished

As the company pulls Blenrep, questions about its future will only intensify.

November 11, 2022

The Parp retreat begins

October 03, 2022

US FDA approval tracker: September 2022

April 22, 2022

What next for developers seeking to emulate Zydelig?

April 19, 2022

The red flags keep coming with TG Therapeutics

January 26, 2022

Incyte follows Gilead in retreating from PI3K delta

January 10, 2022

Avacta’s lateral flow becomes another casualty of Omicron

November 01, 2021

US FDA approval tracker: October 2021

August 02, 2021

US FDA approval tracker: July 2021

June 07, 2021

Medtronic bows to the inevitable

Paying $1.1bn for Heartware five years ago was not the company’s smartest move.

Load More